Scilex Says Private Investment Group to Buy $100M in Newly Issued Shares

Dow Jones
07/06
 
 

Scilex Holding said a private investment group will purchase $100 million of its newly issued shares under a binding term sheet.

The investment will help Scilex expand its healthcare and medical technology initiatives and also support product development, acquisitions and strategic partnerships, working capital and operational growth, intellectual property expansion, as well as other general corporate purposes, the company said Monday.

The purchase price by iHolding Group for the Scilex shares is expected to be $15.00 apiece, which would represent about 6.7 million shares.

The investment is still subject to customary closing conditions.

Scilex focuses on acquiring, developing and commercializing non-opioid pain-management products to treat acute and chronic pain, and neurodegenerative and cardiometabolic diseases.

iHolding is headquartered in the Republic of Kazakhstan.

 

Write to Freddy Sebastian at freddy.sebastian@wsj.com

 

(END) Dow Jones Newswires

July 06, 2026 06:26 ET (10:26 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10